Industry Analysis & Industry Trends
The Veterinary Pharmaceutical Manufacturing industry is a relatively small segment of the general Australian pharmaceutical sector. The industry is involved in the development and manufacture of animal health products including veterinary medicines, vaccines, and other biological and medicinal feed additives. As such, it is geared towards two main segments: food producing animals (including cattle, pigs, poultry and sheep) and companion animals (including cats and dogs). In 2011-12, the industry accounted for just 4.4% of the overall pharmaceutical industry.
Over the five years through 2013-14, the performance of the industry was highly volatile as it contended with a number of external shocks... purchase to read more
Industry Report - Industry SWOT Analysis Chapter
Over the past five years, the industry has witnessed some positive growth in both revenue levels and profit as drought conditions have eased and demand for livestock related products has increased. However, the industry's contribution to the economy is expected to grow by just 0.6% on an annualised basis over the 10 years through 2018-19, well below annualised GDP growth during this period, which is expected to be 2.5%. This is occurring as overall pharmaceutical manufacturing continues to de-emphasise animal health operations in Australia, a trend which is expected to continue. ABS data shows that the industry's revenue as a percentage of total pharmaceutical product manufacturing has decreased from 8.3% in 2001-02 to 4.4% in 2011-12... purchase to read more